Making a plan

You can get a bleed while using HEMLIBRA®. You and your healthcare provider should discuss a plan on when and how to treat and/or manage a bleed. It is important that you stick with the dosing and treatment plan you discussed with your healthcare provider.

What is the most important information I should know about HEMLIBRA?

HEMLIBRA increases the potential for your blood to clot. Carefully follow your healthcare provider’s instructions regarding when to use an on-demand bypassing agent or factor VIII, and the dose and schedule to use for breakthrough bleed treatment. HEMLIBRA may cause serious side effects when used with activated prothrombin complex concentrate (aPCC; FEIBA®), including thrombotic microangiopathy (TMA), and blood clots (thrombotic events). If aPCC (FEIBA®) is needed, talk to your healthcare provider in case you feel you need more than 100 U/kg of aPCC (FEIBA®) total.

For more information, please see the HEMLIBRA Medication Guide.

Find Your Clinical Educator

Get connected with your local Clinical Educator

Additional Resources

Find downloadable resources and information about HEMLIBRA

Side Effects

What you may expect with HEMLIBRA